Novo Nordisk A S
NVO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 1,355 institutions reported holding it in 13F filings for Q2 2026, worth $15.7B in total; superinvestors Markel Group and Maverick Capital hold it.
Other share classesNONOF
Q2 2022 vs. Q1 2022
How the institutions holding Novo Nordisk A S changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 902 | 9 | 934 | +41 |
| Shares | 137.9M | 2.55M | 147.8M | +12.5M (+9.2%) |
| Value | $15.2B | $283.4M | $16.4B | +$1.49B (+10.0%) |
9 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (92)
Institutions that held Novo Nordisk A S at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (51)
Institutions that held Novo Nordisk A S at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (9)
Institutions that held Novo Nordisk A S at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 2,468,869 | $274.2M |
| Susquehanna Fundamental Investments, LLC | 62,020 | $6.89M |
| Barrett Asset Management, LLC | 7,590 | $842.0K |
| American National Insurance Co | 6,000 | $666.0K |
| People's United Financial, Inc. | 2,579 | $286.0K |
| High Pointe Capital Management LLC | 2,280 | $253.0K |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 1,904 | $211.0K |
| Dixon Hughes Goodman Wealth Advisors LLC | 714 | $79.0K |
| SJS Investment Consulting Inc. | 229 | $25.0K |